Oragenics Inc. 8-K Summary
Business Context and Reporting Period
Oragenics Inc. filed this Current Report on Form 8-K on May 23, 2005, to disclose the entry into a material definitive agreement. The company is incorporated in Florida and is based in Alachua, Florida.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or existing debt levels. The primary financial metric disclosed is the potential capital raise of up to $9,000,000 through a new Common Stock Purchase Agreement.
Material Changes
On May 23, 2005, the Company entered into a Common Stock Purchase Agreement with Fusion Capital Fund II, LLC. Key terms include:
- Total Commitment: Fusion Capital agreed to purchase up to $9,000,000 of the Company's common stock.
- Duration: The agreement covers a 30-month period.
- Pricing Mechanism: Shares will be sold at a price based on the market price on the date of sale, with no fixed discount.
- Volume Control: The Company controls the timing and number of shares sold, with a standard daily limit of $15,000 once the registration statement is effective, though the Company may require greater or lesser amounts at its option.
- Registration: A Registration Rights Agreement was signed to file a Form SB-2 registration statement covering the shares.
Outlook, Risks, and Management Commentary
The offering was made pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933. The filing does not provide specific management commentary on future operational outlook, risks, or contingencies beyond the terms of the financing agreement. The success of the capital raise is contingent upon the effectiveness of the Registration Statement.
Investor Verification Checklist
- Verify the effectiveness date of the Form SB-2 Registration Statement to determine when sales can commence.
- Monitor the Company's exercise of its option to control the timing and volume of share sales to assess dilution impact.
- Review the Company's use of proceeds from the $9,000,000 potential raise in subsequent filings.
- Check for any changes in the Company's capital structure or outstanding debt in upcoming periodic reports.